Mentor: Munir Tanas, MD

Comprehensive Exam:

Combined Inhibition of AKT/mTORC1 and TEAD in PI3K-driven Sarcomas

My Research:

My research focuses on improving sarcoma treatment by targeting two critical signaling pathways: PI3K and Hippo. I study how combined inhibition of these pathways can more effectively suppress tumor growth, and work to define the underlying mechanisms, therapeutic windows, and potential clinical applications.

Award:

July 2024-June 2026: Center for Biocatalysis and Bioprocessing – NIH T32 Fellowship